Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07467109 · ClinicalTrials.gov registry record
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- 20
- Enrollment target
NCT07467109: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT07467109 is a clinical trial that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07467109 has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
To learn if drawing blood directly from veins inside the brain is safe and can effectively provide the same kind of detailed information about high-grade glioma as traditional surgical biopsy.
Interventions
- DIAGNOSTIC_TEST blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-19 |
| Est. Completion | 2029-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07467109
The ClinicalTrials.gov registry entry for NCT07467109 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood sampling is the first listed.
NCT07467109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07467109 about?
NCT07467109 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers". To learn if drawing blood directly from veins inside the brain is safe and can effectively provide the same kind of detailed information about high-grade glioma as traditional surgical biopsy.
What is the current status of trial NCT07467109?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-08-19. Estimated completion is 2029-05-01.
What interventions are being tested in trial NCT07467109?
The interventions under investigation include: blood sampling (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07467109?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.